UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 241

Sortiert nach

Differential diagnosis of suspected multiple sclerosis: a consensus approach

Multiple sclerosis, 2008-11, Vol.14 (9), p.1157-1174

2008

Link zum Volltext

Verfügbarkeit prüfen

Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate

Multiple sclerosis, 2010-03, Vol.16 (3), p.342-350

2010

Link zum Volltext

Verfügbarkeit prüfen

A prospective open-label study of glatiramer acetate: over a decade of continuous use in multiple sclerosis patients

Multiple sclerosis, 2006-06, Vol.12 (3), p.309-320

2006

Link zum Volltext

Verfügbarkeit prüfen

Influence of infection on exacerbations of multiple sclerosis

Annals of neurology, 1994, Vol.36 (S1), p.S25-S28

Panitch, Hillel S.

1994

Link zum Volltext

Verfügbarkeit prüfen

Glatiramer acetate after induction therapy with mitoxantrone in relapsing multiple sclerosis

Multiple sclerosis, 2008-06, Vol.14 (5), p.663-670

2008

Link zum Volltext

Verfügbarkeit prüfen

Developmental changes in chest wall compliance in infancy and early childhood

Journal of applied physiology (1985), 1995-01, Vol.78 (1), p.179

1995

Link zum Volltext

Verfügbarkeit prüfen

Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment

Neurology, 2008-03, Vol.70 (13 Pt 2), p.1134

2008

Link zum Volltext

Verfügbarkeit prüfen

Glatiramer acetate after mitoxantrone induction improves MRI markers of lesion volume and permanent tissue injury in MS

Journal of neurology, 2008-10, Vol.255 (10), p.1473-1478

2008

Link zum Volltext

Verfügbarkeit prüfen

Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years

Multiple sclerosis, 2000-08, Vol.6 (4), p.255-266

2000

Link zum Volltext

Verfügbarkeit prüfen

Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years

Multiple sclerosis, 2000-04, Vol.6 (4), p.255-266

2000

Link zum Volltext

Verfügbarkeit prüfen

The effects of 4-aminopyridine in multiple sclerosis patients: results of a randomized, placebo-controlled, double-blind, concentration-controlled, crossover trial

Neurology, 1994-06, Vol.44 (6), p.1054

1994

Link zum Volltext

Verfügbarkeit prüfen

Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange

The Lancet (British edition), 2005-08, Vol.366 (9485), p.579-582

2005

Link zum Volltext

Verfügbarkeit prüfen

Bronchiolitis in infants

Current opinion in pediatrics, 2001-06, Vol.13 (3), p.256-260

Panitch, H B

2001

Link zum Volltext

Verfügbarkeit prüfen

Interferons in multiple sclerosis : a review of the evidence

Drugs (New York, N.Y.), 1992-12, Vol.44 (6), p.946-962

PANITCH, H. S

1992

Link zum Volltext

Verfügbarkeit prüfen

Intramedullary spinal cord abscess in a healthy woman

Neurology, 2007-04, Vol.68 (15), p.1230

2007

Link zum Volltext

Verfügbarkeit prüfen

Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: A multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon β-1a for relapsing multiple sclerosis

Clinical therapeutics, 2007-09, Vol.29 (9), p.2031-2048

2007

Link zum Volltext

Verfügbarkeit prüfen

Serial combination therapy: is immune modulation in multiple sclerosis enhanced by initial immune suppression?

Multiple sclerosis, 2009-08, Vol.15 (8), p.959-964

2009

Link zum Volltext

Verfügbarkeit prüfen

Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis

The New England journal of medicine, 2008-10, Vol.359 (17), p.1786-1801

2008

Link zum Volltext

Verfügbarkeit prüfen

Respiratory Care of the patient with duchenne muscular dystrophy: ATS Consensus statement

American journal of respiratory and critical care medicine, 2004-08, Vol.170 (4), p.456-465

2004

Link zum Volltext

Verfügbarkeit prüfen

Exacerbations of multiple sclerosis in patients treated with gamma interferon

The Lancet (British edition), 1987-04, Vol.1 (8538), p.893-895

1987

Link zum Volltext

Verfügbarkeit prüfen

Randomized study combining interferon and glatiramer acetate in multiple sclerosis

Annals of neurology, 2013-03, Vol.73 (3), p.327-340

2013

Link zum Volltext

Verfügbarkeit prüfen

Randomized, comparative study of interferon beta-1a treatment regimens in MS: The EVIDENCE Trial

Neurology, 2002-11, Vol.59 (10), p.1496

2002

Link zum Volltext

Verfügbarkeit prüfen

Interferon beta-1b in secondary progressive MS: results from a 3-year controlled study

Neurology, 2004-11, Vol.63 (10), p.1788

2004

Link zum Volltext

Verfügbarkeit prüfen

Interferon beta-1b serum levels in multiple sclerosis patients following subcutaneous administration

Neurology, 1996-06, Vol.46 (6), p.1639

1996

Link zum Volltext

Verfügbarkeit prüfen

A70 PULMONARY REHABILITATION IN LUNG TRANSPLANTATION AND THE ACUTE SETTING: View Of Directors Of Home Ventilation Programs On Decisions Around Long-Term Ventilation

American journal of respiratory and critical care medicine, 2017-01, Vol.195

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 241

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(217)
Mit Volltextzugriff
(172)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Differential diagnosis of suspected multiple sclerosis: a consensus approach

Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate

A prospective open-label study of glatiramer acetate: over a decade of continuous use in multiple sclerosis patients

Influence of infection on exacerbations of multiple sclerosis

Glatiramer acetate after induction therapy with mitoxantrone in relapsing multiple sclerosis

Developmental changes in chest wall compliance in infancy and early childhood

Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment

Glatiramer acetate after mitoxantrone induction improves MRI markers of lesion volume and permanent tissue injury in MS

Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years

Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years

The effects of 4-aminopyridine in multiple sclerosis patients: results of a randomized, placebo-controlled, double-blind, concentration-controlled, crossover trial

Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange

Bronchiolitis in infants

Interferons in multiple sclerosis : a review of the evidence

Intramedullary spinal cord abscess in a healthy woman

Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: A multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon β-1a for relapsing multiple sclerosis

Serial combination therapy: is immune modulation in multiple sclerosis enhanced by initial immune suppression?

Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis

Respiratory Care of the patient with duchenne muscular dystrophy: ATS Consensus statement

Exacerbations of multiple sclerosis in patients treated with gamma interferon

Randomized study combining interferon and glatiramer acetate in multiple sclerosis

Randomized, comparative study of interferon beta-1a treatment regimens in MS: The EVIDENCE Trial

Interferon beta-1b in secondary progressive MS: results from a 3-year controlled study

Interferon beta-1b serum levels in multiple sclerosis patients following subcutaneous administration

A70 PULMONARY REHABILITATION IN LUNG TRANSPLANTATION AND THE ACUTE SETTING: View Of Directors Of Home Ventilation Programs On Decisions Around Long-Term Ventilation

Suchergebnisse filtern